Skip to main content

UPDATE 2-Bristol profit tops forecast, scales back 2013 ambitions

*Sales $4.19 bln vs Street view $4.12 bln. Jan 24- Bristol-Myers Squibb Co reported better-than-expected quarterly results on Thursday, lifting its shares 2.7 percent, but scaled back its 2013 earnings forecast following setbacks for several of its experimental drugs.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.